Settore Hansa Biopharma AB

Azioni

HNSA

SE0002148817

Biotecnologia

Mercato chiuso - Nasdaq Stockholm 18:00:00 13/02/2026 Variaz. 5gg Var. 1 gen.
40,00 SEK -2,39% Grafico intraday di Hansa Biopharma AB +10,44% +16,41%
Principali concorrenti
Variaz. Variaz. 5g. Variazione 1 mese Variazione 3 mesi Variaz. 1 gen. Variaz. 1 anno Variaz. 3 anni Variaz. 5 anni Variaz. 10 anni Capi.($)
-2,39%+10,44%+16,55%+51,40%+16,41%+72,41%-23,59%-79,41%+86,05% 455 Mln
+4,62%+0,73%-6,63%-4,30%-3,12%-12,50%-4,72%-14,59%+277,26% 47,61 Mrd
-0,10%-2,22%+2,30%-5,40%+13,91%+49,90%+44,95%-9,12%+1.343,16% 38,3 Mrd
-0,21%+8,18%+12,53%+21,37%+31,49%+36,90%+61,03%-16,96%+222,56% 36,11 Mrd
-1,13%-10,96%-30,81%-24,33%-25,94%-13,70%-26,47%-13,35%+176,25% 28,31 Mrd
-1,05%-1,21%-21,87%+42,15%+20,92%+136,81%+277,09%+93,47% - 18,62 Mrd
+7,58%+14,65%+3,86%+147,78%+48,67%+31.531,21%+4.130,93% - - 15,44 Mrd
+2,25%-3,74%-9,08%+11,02%+4,90%+31,21%-3,02%-19,63%+134,29% 13,71 Mrd
-0,82%-2,62%+0,60%+5,83%+1,44%+50,14%+93,14%+34,64%+1.076,29% 13,28 Mrd
-1,44%-6,82%+4,39%+12,65%+1,88%+159,66%+108,92%+41,25%+125,52% 13,06 Mrd
+2,88%-21,03%-30,74%-27,46%-23,79%+25,83%+105,78%+154,39% - 12,15 Mrd
-0,87%-1,06%+4,20%+8,05%+6,49%+20,11%-6,82%-19,38%+109,59% 10,39 Mrd
+2,12%+9,60%-1,67%+12,74%-11,79%+1.459,47%+1.480,36%+227,78%+693,72% 9,81 Mrd
+0,79%-10,26%-14,34%+0,93%+1,90%-9,11%-21,97%-39,90%+183,42% 9,38 Mrd
+2,30%-5,39%-24,62%-24,14%-12,02%-41,92% - - - 9,24 Mrd
-4,71%-0,73%+6,55%+70,18%+7,64%+249,51%+471,62%-59,74% - 8,8 Mrd
+1,64%-14,72%-27,80%-3,85%-19,11%+6,16%-35,85%-44,89%+123,88% 7,94 Mrd
-2,70%-0,99%-9,15%-5,02%+5,17%+11,78%-33,51%-56,60% - 7,33 Mrd
-4,90%-7,27%-3,37%+5,15%+7,37%+9,26%-49,80%-68,02%+227,08% 7,22 Mrd
+16,13%-38,24%-49,06%-42,66%-48,96%-50,06%-60,43%-55,82%+39,26% 7,1 Mrd
Media +1,00%-4,41%-8,91%+12,60%+1,17%+1.686,15%+342,51%+3,01%+344,17% 15,71 Mrd
Media ponderata per Capi. +1,21%-3,10%-7,50%+9,86%+4,05%+1.626,79%+304,43%+6,04%+445,22%
Biotecnologia e ricerca medica - Altri
  1. Mercati
  2. Azioni
  3. Azione HNSA
  4. Settore Hansa Biopharma AB